Cargando…
Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function
BACKGROUND: It has long been recognized that vitamin D deficiency is associated with muscle weakness and falls. Vitamin D receptor (VDR) is present at very low levels in normal muscle. Whether vitamin D plays a direct role in muscle function is unknown and is a subject of hot debate. Myocyte‐specifi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903451/ https://www.ncbi.nlm.nih.gov/pubmed/31225722 http://dx.doi.org/10.1002/jcsm.12460 |
_version_ | 1783477851125710848 |
---|---|
author | Girgis, Christian M. Cha, Kuan Minn So, Benjamin Tsang, Michael Chen, Jennifer Houweling, Peter J. Schindeler, Aaron Stokes, Rebecca Swarbrick, Michael M. Evesson, Frances J. Cooper, Sandra T. Gunton, Jenny E. |
author_facet | Girgis, Christian M. Cha, Kuan Minn So, Benjamin Tsang, Michael Chen, Jennifer Houweling, Peter J. Schindeler, Aaron Stokes, Rebecca Swarbrick, Michael M. Evesson, Frances J. Cooper, Sandra T. Gunton, Jenny E. |
author_sort | Girgis, Christian M. |
collection | PubMed |
description | BACKGROUND: It has long been recognized that vitamin D deficiency is associated with muscle weakness and falls. Vitamin D receptor (VDR) is present at very low levels in normal muscle. Whether vitamin D plays a direct role in muscle function is unknown and is a subject of hot debate. Myocyte‐specific deletion of VDR would provide a strategy to answer this question. METHODS: Myocyte‐specific vitamin D receptor (mVDR) null mice were generated by crossing human skeletal actin‐Cre mice with floxed VDR mice. The effects of gene deletion on the muscle phenotype were studied in terms of body tissue composition, muscle tissue histology, and gene expression by real‐time PCR. RESULTS: Unlike whole‐body VDR knockout mice, mVDR mice showed a normal body size. The mVDR showed a distinct muscle phenotype featuring reduced proportional lean mass (70% vs. 78% of lean mass), reduced voluntary wheel‐running distance (22% decrease, P = 0.009), reduced average running speed, and reduced grip strength (7–16% reduction depending on age at testing). With their decreased voluntary exercise, and decreased lean mass, mVDR have increased proportional fat mass at 20% compared with 13%. Surprisingly, their muscle fibres showed slightly increased diameter, as well as the presence of angular fibres and central nuclei suggesting ongoing remodelling. There were, however, no clear changes in fibre type and there was no increase in muscle fibrosis. VDR is a transcriptional regulator, and changes in the expression of candidate genes was examined in RNA extracted from skeletal muscle. Alterations were seen in myogenic gene expression, and there was decreased expression of cell cycle genes cyclin D1, D2, and D3 and cyclin‐dependent kinases Cdk‐2 and Cdk‐4. Expression of calcium handling genes sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) Serca2b and Serca3 was decreased and Calbindin mRNA was lower in mVDR muscle. CONCLUSIONS: This study demonstrates that vitamin D signalling is needed for myocyte function. Despite the low level of VDR protein normally found muscle, deleting myocyte VDR had important effects on muscle size and strength. Maintenance of normal vitamin D signalling is a useful strategy to prevent loss of muscle function and size. |
format | Online Article Text |
id | pubmed-6903451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69034512019-12-19 Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function Girgis, Christian M. Cha, Kuan Minn So, Benjamin Tsang, Michael Chen, Jennifer Houweling, Peter J. Schindeler, Aaron Stokes, Rebecca Swarbrick, Michael M. Evesson, Frances J. Cooper, Sandra T. Gunton, Jenny E. J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: It has long been recognized that vitamin D deficiency is associated with muscle weakness and falls. Vitamin D receptor (VDR) is present at very low levels in normal muscle. Whether vitamin D plays a direct role in muscle function is unknown and is a subject of hot debate. Myocyte‐specific deletion of VDR would provide a strategy to answer this question. METHODS: Myocyte‐specific vitamin D receptor (mVDR) null mice were generated by crossing human skeletal actin‐Cre mice with floxed VDR mice. The effects of gene deletion on the muscle phenotype were studied in terms of body tissue composition, muscle tissue histology, and gene expression by real‐time PCR. RESULTS: Unlike whole‐body VDR knockout mice, mVDR mice showed a normal body size. The mVDR showed a distinct muscle phenotype featuring reduced proportional lean mass (70% vs. 78% of lean mass), reduced voluntary wheel‐running distance (22% decrease, P = 0.009), reduced average running speed, and reduced grip strength (7–16% reduction depending on age at testing). With their decreased voluntary exercise, and decreased lean mass, mVDR have increased proportional fat mass at 20% compared with 13%. Surprisingly, their muscle fibres showed slightly increased diameter, as well as the presence of angular fibres and central nuclei suggesting ongoing remodelling. There were, however, no clear changes in fibre type and there was no increase in muscle fibrosis. VDR is a transcriptional regulator, and changes in the expression of candidate genes was examined in RNA extracted from skeletal muscle. Alterations were seen in myogenic gene expression, and there was decreased expression of cell cycle genes cyclin D1, D2, and D3 and cyclin‐dependent kinases Cdk‐2 and Cdk‐4. Expression of calcium handling genes sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) Serca2b and Serca3 was decreased and Calbindin mRNA was lower in mVDR muscle. CONCLUSIONS: This study demonstrates that vitamin D signalling is needed for myocyte function. Despite the low level of VDR protein normally found muscle, deleting myocyte VDR had important effects on muscle size and strength. Maintenance of normal vitamin D signalling is a useful strategy to prevent loss of muscle function and size. John Wiley and Sons Inc. 2019-06-21 2019-12 /pmc/articles/PMC6903451/ /pubmed/31225722 http://dx.doi.org/10.1002/jcsm.12460 Text en © 2019 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Girgis, Christian M. Cha, Kuan Minn So, Benjamin Tsang, Michael Chen, Jennifer Houweling, Peter J. Schindeler, Aaron Stokes, Rebecca Swarbrick, Michael M. Evesson, Frances J. Cooper, Sandra T. Gunton, Jenny E. Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function |
title | Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function |
title_full | Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function |
title_fullStr | Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function |
title_full_unstemmed | Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function |
title_short | Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function |
title_sort | mice with myocyte deletion of vitamin d receptor have sarcopenia and impaired muscle function |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903451/ https://www.ncbi.nlm.nih.gov/pubmed/31225722 http://dx.doi.org/10.1002/jcsm.12460 |
work_keys_str_mv | AT girgischristianm micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT chakuanminn micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT sobenjamin micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT tsangmichael micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT chenjennifer micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT houwelingpeterj micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT schindeleraaron micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT stokesrebecca micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT swarbrickmichaelm micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT evessonfrancesj micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT coopersandrat micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction AT guntonjennye micewithmyocytedeletionofvitamindreceptorhavesarcopeniaandimpairedmusclefunction |